Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a peptide gummy soothe sore muscles and speed recovery?

NCT ID NCT07752381

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This trial tests whether daily peptide gummies containing BPC-157 can ease inflammation and improve recovery in physically active adults. Over 8 weeks, 40 participants will take two gummies daily and report on muscle aching, stiffness, and function, with blood tests measuring inflammatory markers at the start and end. The goal is to see if this supplement supports the body's natural recovery process after exercise.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Parlay Recover peptide gummies containing Body Protection Compound (BPC-157)
What this could lead to
If effective, these gummies could offer a convenient way to support muscle recovery and reduce exercise-related inflammation.
What could go wrong
This is a small, early-stage study without a placebo group, so results may not prove the gummies work. Individual responses can vary, and the supplement's long-term safety is not fully known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Sep 2025

Finished

Nov 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be male or female. * Be aged 18-65. * Engages in structured physical activity ≥3 times per week, with each session lasting at least 30 minutes, over the past 3 months (e.g., running, gym/strength training, cycling, team sports, fitness classes). * Within the last 4 weeks, reports post-exercise musculoskeletal symptoms (aching, stiffness, or delayed recovery) at least once per week. * Willing to maintain current exercise routine throughout the 8-week study (no major changes in frequency, intensity, or new training programs). * Anyone who is generally healthy - does not live with any uncontrolled chronic disease. * If taking products or supplements that target muscle and joint health, has been consistently taking these for at least 3 months prior to starting the study, and is willing to maintain this routine for the study duration. * Willing to maintain the same diet and sleep schedule throughout the study duration. * Resides in the United States. Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. * Use of specialized recovery modalities (e.g., cryotherapy, frequent sports massage, IV nutrition, high-dose recovery supplements) started within the past 8 weeks or expected to be initiated during the trial. * Acute illness or infection within 14 days prior to Baseline (e.g., fever, flu, COVID-19) or planned surgery during the study. * History of inflammatory or autoimmune conditions, including but not limited to rheumatoid arthritis, lupus, inflammatory bowel disease (IBD), ankylosing spondylitis, Hashimoto's thyroiditis, or Grave's disease. * Use of systemic corticosteroids (such as prednisone) within past 8 weeks. * Recent intra-articular steroid injection within 12 weeks. * Anyone with any allergies or sensitivities to any of the study product ingredients. * Anyone who is a heavy drinker (i.e. 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men). * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period). * Anyone with uncontrolled chronic diseases, including but not limited to hypertension (high blood pressure) and diabetes. * Anyone unwilling to follow the study protocol. * Anyone with nut sensitivity or allergy. * Anyone with a history of substance abuse. * Musculoskeletal injury within the past 8 weeks that required any type of modification in your exercise routine. * Planning on introducing any new products, prescription medications, or supplements that target muscle health, joint health, or exercise performance for the study duration. * Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration. * Anyone with a history of hypotension. * Anyone who is currently taking antihypertensive medication.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Exercise induced muscle damage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Musculoskeletal Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.